Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
Top Cited Papers
Open Access
- 30 October 2006
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 25 (51) , 6817-6830
- https://doi.org/10.1038/sj.onc.1209942
Abstract
Abundant data support a key role for the transcription factor nuclear factor-κB (NF-κB) signaling pathway in controlling the initiation and progression of human cancer. NF-κB and associated regulatory proteins such as IκB kinase (IKK) are activated downstream of many oncoproteins and there is much evidence for the activation of NF-κB-dependent target genes in a variety of solid tumors and hematologic malignancies. This review focuses on the mechanisms by which the NF-κB pathway is activated in cancer and on the oncogenic functions controlled by activated NF-κB. Additionally, the effects of NF-κB activation in tumors relative to cancer therapy are also discussed.Keywords
This publication has 146 references indexed in Scilit:
- Inhibitors of NF-κB signaling: 785 and countingOncogene, 2006
- Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significanceOncogene, 2006
- Nuclear factor-κB in cancer development and progressionNature, 2006
- A loss-of-function RNA interference screen for molecular targets in cancerNature, 2006
- To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosisOncogene, 2003
- NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasiaNature, 2003
- Inflammation and cancerNature, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- STATs in oncogenesisOncogene, 2000
- The Hallmarks of CancerCell, 2000